...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The Australian and New Zealand journal of psychiatry >Correlates of antidepressant and anxiolytic, hypnotic or sedative medication use in an Australian community sample.
【24h】

Correlates of antidepressant and anxiolytic, hypnotic or sedative medication use in an Australian community sample.

机译：澳大利亚社区样本中抗抑郁药和抗焦虑药，催眠药或镇静药的使用相关。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

OBJECTIVE: To explore the rates and correlates of antidepressant (AD) and anxiolytic, hypnotic or sedative (AHS) medication use in Australia, and describe possible reasons for their use. METHOD: Analysis of data from the 2007 National Survey of Mental Health and Wellbeing, a nationally representative household survey of 8841 Australians aged 16 to 85 years. Two primary outcome variables: (i) use of any AD medication; and (ii) use of any AHS medication, in the past 2 weeks. RESULTS: Rates of AD and AHS medication use were 6.8% and 4.7% respectively. AD and AHS medication use were each associated with 12-month affective or anxiety disorder, age, chronic physical illness, sleep difficulties, and impaired role functioning. Psychological distress and lifetime affective or anxiety disorder or 12-month symptoms were associated with AD use; being previously married was associated with AHS use. Potential reasons for use are complex. Almost one third (30.6%) of AD users and half (49.2%) of AHS users did not report symptoms consistent with a 12-month or lifetime affective or anxiety disorder. Chronic physical illness was reported by 68.8% of AD users and 73.5% of AHS users, around half of whom had a 12-month mental disorder. People with mental-physical comorbidity had especially high rates of AD and AHS use. People with musculoskeletal and other conditions that may involve chronic pain had elevated rates of AD and AHS use, even in the absence of a mental disorder. CONCLUSIONS: Low rates of medication use in younger adults and high rates of AHS use in older people warrant further investigation. Many AD and AHS users were not assessed as having an affective or anxiety disorder, suggesting that these medications are frequently used for other indications. Findings call for further research to explore the relationship between mental disorders, physical conditions and medication use.
机译：目的：探讨在澳大利亚使用抗抑郁药（AD）和抗焦虑药，催眠药或镇静药（AHS）的比率和相关性，并描述其使用的可能原因。方法：对2007年全国心理健康与幸福调查的数据进行分析，该调查是对8841名16至85岁澳大利亚人的全国性家庭调查。两个主要的结果变量：（i）使用任何抗逆转录病毒药物; （ii）在过去2周内使用任何AHS药物。结果：AD和AHS药物的使用率分别为6.8％和4.7％。 AD和AHS药物的使用均与12个月的情感或焦虑症，年龄，慢性身体疾病，睡眠困难和角色功能受损有关。心理障碍和终身情感或焦虑症或12个月的症状与使用AD有关;以前结婚与使用AHS有关。使用的潜在原因很复杂。几乎三分之一（30.6％）的AD用户和一半（49.2％）的AHS用户未报告与12个月或终生的情感或焦虑症相一致的症状。 68.8％的AD用户和73.5％的AHS用户报告了慢性身体疾病，其中大约一半患有12个月的精神障碍。患有精神和身体合并症的人使用AD和AHS的比例特别高。即使在没有精神障碍的情况下，患有肌肉骨骼疾病和其他可能涉及慢性疼痛的人，AD和AHS的使用率也会升高。结论：在年轻人中低药物使用率和在老年人中高AHS使用率值得进一步研究。许多AD和AHS使用者没有被评估为患有情感或焦虑症，这表明这些药物经常用于其他适应症。研究结果需要进一步研究，以探索精神障碍，身体状况和药物使用之间的关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号